We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microchip Technology Screens for More Than 1000 Molecules

By LabMedica International staff writers
Posted on 06 Aug 2009
Scientists have developed technology to perform over a thousand chemical reactions at once on a stamp-size, PC-controlled microchip.

The technology, which is based on microfluidics, utilized miniaturized devices to automatically handle and channel tiny amounts of liquids and chemicals invisible to the eye. The chemical reactions were performed using in situ click chemistry, and analyzed using mass spectrometry.

A thousand cycles of complex processes, including controlled sampling and mixing of a library of reagents and sequential microchannel rinsing, all took place on the microchip device and were completed in a few hours. Developed by a University of California, Los Angeles (UCLA; Los Angeles, CA, USA) team, the technology is restricted to analyzing the reaction results offline, but the aim is to automate this aspect of the work also. It could accelerate the identification of potential drug candidates for treating diseases like cancer.

The team intends to utilize the technology for diagnostic screening reactions in which chemicals and material samples are in limited supply; e.g., protein enzymes such as kinases that play critical roles in the malignant transformation of cancer. According to the scientists, the technology will open up many areas for biologic and medicinal study.

"The precious enzyme molecules required for a single in situ click reaction in a traditional lab now can be split into hundreds of duplicates for performing hundreds of reactions in parallel, thus revolutionizing the laboratory process, reducing reagent consumption and accelerating the process for identifying potential drug candidates," said study author Prof. Hsian-Rong Tseng, scientist at UCLA's Crump Institute for Molecular Imaging, associate professor molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, and a member of the California NanoSystems Institute at UCLA.

The Study appeared online in the August 2009 edition of Science Daily.

Related Links:
University of California, Los Angeles
Science Daily


New
Gold Member
Collection and Transport System
PurSafe PlusĀ®
Collection and Transport System
PurSafe PlusĀ®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Capillary Blood Collection Tube
IMPROMINI M3

Latest Clinical Chem. News

VOCs Show Promise for Early Multi-Cancer Detection
06 Aug 2009  |   Clinical Chem.

Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
06 Aug 2009  |   Clinical Chem.

Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
06 Aug 2009  |   Clinical Chem.



GLOBE SCIENTIFIC, LLC